Dr. Daniel Rosen
Onward with Rosie O'Donnell
The Safety and Effectiveness of Wigovi
Ozempic slash wigovi, which is generically known as semaglutide, has been approved for adolescents. "It's a tricky area, especially in today's like political environment to talk about like medicating kids," she says. Wigovi was approved for adolescents 12 to 18 years old without tons of data that demonstrates safety and efficacy or that it works.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
